R. W. AMMANN, M.D.; J. EDWARD BERK, M.D., F.A.C.P.; LOUIS FRIDHANDLER; MASATOSHI UEDA, M.D.; W. WEGMANN, M.D.
AMMANN RW, BERK JE, FRIDHANDLER L, UEDA M, WEGMANN W. Hyperamylasemia with Carcinoma of the Lung. Ann Intern Med. 1973;78:521-525. doi: 10.7326/0003-4819-78-4-521
Download citation file:
Published: Ann Intern Med. 1973;78(4):521-525.
Two patients with pronounced hyperamylasemia and hyperamylasuria, associated with metastatic carcinoma of the lung, are described. The primary lung tumor in the one patient with tissue available for assay contained adrenocorticotrophin and had a pronounced degree of amylase activity. Ion exchange chromatography further showed that the motility pattern of the amylase in the serum, urine, and tumor tissue of this patient resembled salivary amylase. Assay of metastatic lesions in both patients showed amylase activity levels that exceeded those in the serum. These observations indicate that amylase may be produced ectopically in some carcinomatous lung tumors and that amylase of this origin may cause pronounced and persistent hyperamylasemia.
Learn more about subscription options.
Register Now for a free account.
Hematology/Oncology, Lung Cancer, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only